Cargando…
MiR-29 Regulates de novo Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner
MicroRNAs (miRNAs) are known regulators of lipid homeostasis. We recently demonstrated that miR-29 controls the levels of circulating cholesterol and triglycerides, but the mechanisms remained unknown. In the present study, we demonstrated that systemic delivery of locked nucleic acid inhibitor of m...
Autores principales: | Hung, Yu-Han, Kanke, Matt, Kurtz, Catherine Lisa, Cubitt, Rebecca L., Bunaciu, Rodica P., Zhou, Liye, White, Phillip J., Vickers, Kasey C., Hussain, Mohammed Mahmood, Li, Xiaoling, Sethupathy, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828850/ https://www.ncbi.nlm.nih.gov/pubmed/31736786 http://dx.doi.org/10.3389/fphys.2019.01367 |
Ejemplares similares
-
Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver
por: Kurtz, C. Lisa, et al.
Publicado: (2015) -
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022) -
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients
por: Lawitz, Eric J., et al.
Publicado: (2022) -
SLC16A7 Promotes Triglyceride Deposition by De Novo Lipogenesis in Chicken Muscle Tissue
por: Wang, Yongli, et al.
Publicado: (2022) -
MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes
por: Kurtz, C. Lisa, et al.
Publicado: (2014)